Henry Schein, Inc. Expected to Post Q3 2024 Earnings of $1.16 Per Share (NASDAQ:HSIC)

Henry Schein, Inc. (NASDAQ:HSIC) – Equities research analysts at Zacks Research decreased their Q3 2024 earnings per share (EPS) estimates for shares of Henry Schein in a note issued to investors on Friday, September 13th. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $1.16 for the quarter, down from their previous forecast of $1.21. The consensus estimate for Henry Schein’s current full-year earnings is $4.75 per share. Zacks Research also issued estimates for Henry Schein’s FY2024 earnings at $4.73 EPS, Q3 2025 earnings at $1.36 EPS, FY2025 earnings at $5.20 EPS and FY2026 earnings at $5.68 EPS.

HSIC has been the subject of several other reports. Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. UBS Group decreased their target price on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. Evercore ISI reduced their price objective on shares of Henry Schein from $72.00 to $70.00 and set an “in-line” rating for the company in a research report on Wednesday, August 7th. Piper Sandler reaffirmed an “overweight” rating and set a $86.00 price target on shares of Henry Schein in a research note on Friday, June 21st. Finally, JPMorgan Chase & Co. decreased their price objective on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a report on Monday, August 12th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Henry Schein currently has an average rating of “Hold” and an average target price of $77.10.

Henry Schein Trading Up 2.0 %

HSIC opened at $71.24 on Monday. The stock has a market cap of $9.12 billion, a PE ratio of 24.07, a price-to-earnings-growth ratio of 1.88 and a beta of 0.86. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. Henry Schein has a twelve month low of $60.01 and a twelve month high of $82.63. The company has a fifty day moving average of $69.32 and a 200-day moving average of $70.43.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. The business had revenue of $3.10 billion during the quarter, compared to the consensus estimate of $3.27 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The company’s revenue for the quarter was up .0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.31 EPS.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the business. BNP Paribas Financial Markets boosted its position in shares of Henry Schein by 36.0% during the fourth quarter. BNP Paribas Financial Markets now owns 82,517 shares of the company’s stock valued at $6,247,000 after purchasing an additional 21,838 shares in the last quarter. ING Groep NV grew its stake in shares of Henry Schein by 9.0% in the 4th quarter. ING Groep NV now owns 17,877 shares of the company’s stock worth $1,353,000 after buying an additional 1,483 shares during the last quarter. Norges Bank purchased a new position in Henry Schein during the fourth quarter valued at $111,715,000. MainStreet Investment Advisors LLC boosted its holdings in Henry Schein by 8.5% in the fourth quarter. MainStreet Investment Advisors LLC now owns 6,519 shares of the company’s stock worth $494,000 after acquiring an additional 508 shares in the last quarter. Finally, PNC Financial Services Group Inc. grew its stake in shares of Henry Schein by 5.6% in the fourth quarter. PNC Financial Services Group Inc. now owns 87,085 shares of the company’s stock worth $6,593,000 after acquiring an additional 4,591 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Insider Buying and Selling at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the transaction, the senior vice president now directly owns 71,833 shares in the company, valued at approximately $4,978,026.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.